Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Friday, June 19, 2026

Chemiluminescence Immunoassay (CLIA) Analyzer Market in United States: Trends, Forecast and Competitive Analysis to 2035

According to a market report by Lucintel, the future of the chemiluminescence immunoassay (CLIA) analyzer market in United States looks promising with opportunities in the therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease testing, and autoimmune disease markets. The chemiluminescence immunoassay (CLIA) analyzer market in United States is expected to grow with a CAGR of 8% from 2026 to 2035. The chemiluminescence immunoassay (CLIA) analyzer market in United States is also forecasted to witness strong growth over the forecast period. The major drivers for this market are the increasing prevalence of chronic diseases, the growing demand for early diagnostics, and the rising investments in healthcare infrastructure.

A more than 150-page report to understand trends, opportunity and forecast in chemiluminescence immunoassay (CLIA) analyzer market in United States to 2035 by type (semi-automated CLIA analyzers and fully automated CLIA analyzers) and application (therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease testing, autoimmune disease, and others).

Download sample by clicking on chemiluminescence immunoassay (CLIA) analyzer market in United States.

Lucintel forecasts that, within the type category, the fully automated CLIA analyzer is expected to witness higher growth over the forecast period.

Within the application category, infectious disease testing is expected to witness the highest growth.

 This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email:
roy.almaguer@lucintel.com
Tel. +1-972-636-5056

Explore Our Latest Publications

Chemiluminescence Immunoassay (CLIA) Analyzer Market in Australia

Chemiluminescence Immunoassay (CLIA) Analyzer Market in Brazil

Chemiluminescence Immunoassay (CLIA) Analyzer Market in Canada

Chemiluminescence Immunoassay (CLIA) Analyzer Market in Mexico

Chemiluminescence Immunoassay (CLIA) Analyzer Market in Saudi Arabia

Chemiluminescence Immunoassay (CLIA) Analyzer Market in South Africa

No comments:

Post a Comment